The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Vanda Pharmaceuticals Inc

Nasdaq: VNDA
Last

(U.S.) $14.90

Today's change0.00 0.00%
Updated April 25 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Vanda Pharmaceuticals Inc

Nasdaq: VNDA
Last

(U.S.) $14.90

Today's change0.00 0.00%
Updated April 25 4:00 PM -4GMT. Delayed by at least 15 minutes.

Vanda Pharmaceuticals Inc closed at (U.S.)$14.90.

Over the last five days, shares have gained 3.47%, but are down 6.58% for the last year to date. Shares have outperformed the S&P 500 by 42.43% during the last year.

Key company metrics

  • Open(U.S.) $14.85
  • Previous close(U.S.) $14.90
  • High(U.S.) $15.10
  • Low(U.S.) $14.85
  • Bid / Ask(U.S.) $11.60 / (U.S.) $0.00
  • YTD % change-6.58%
  • Volume457,075
  • Average volume (10-day)414,437
  • Average volume (1-month)479,646
  • Average volume (3-month)565,933
  • 52-week range(U.S.) $8.04 to (U.S.) $18.00
  • Beta1.43
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.42
Updated April 25 4:00 PM -4GMT. Delayed by at least 15 minutes.

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue38383633
Total other revenue--------
Total revenue38383633
Gross profit33313027
Total cost of revenue5766
Total operating expense39394146
Selling / general / administrative24222529
Research & development8778
Depreciation / amortization2333
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-1-1-5-12
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-10-5-12
Income after tax-10-5-12
Income tax, total0------
Net income-10-5-12
Total adjustments to net income--------
Net income before extra. items-10-5-12
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-10-5-12
Inc. avail. to common incl. extra. items-10-5-12
Diluted net income-10-5-12
Dilution adjustment--------
Diluted weighted average shares44444343
Diluted EPS excluding extraordinary itemsvalue per share-0.01-0.01-0.11-0.29
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.01-0.01-0.11-0.29